Esperer Nutrition

Esperer Nutrition Group is a research-based global clinical nutrition organization established in 2019, headquartered in Mumbai, India, and London, UK. With a focus on onco-nutrition, the company holds multiple international patents and operates India's first Cancer Nutrition Research Centre (ENDC). The hallmark of Esperer Nutrition's research is the "DINI AXIS," which aims to lower the risk of NCDs (Non-Communicable Diseases). The company's vision encompasses a 360-degree solution, from disease management to nutritional intervention in preventive care, with an emphasis on addressing drug-nutrient interactions in chronic disease management.

Esperer Nutrition's last investment was a Venture Round investment on 15 April 2020, which was led by Zenfold Ventures. The company operates in the Healthcare and Nutrition industries and is positioned to make a significant impact on the global clinical nutrition market, leveraging its innovative research and strategic partnerships.